CFTR MRNA compositions and related methods and uses
US10420791B2 · kind B2 · utility
0Cited by
251References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 16, 2017 |
| Grant date | Sep 24, 2019 |
| Priority date | — |
| Expiry date | Jun 16, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y306/03049
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is particularly useful for treating cystic fibrosis. The disclosure concerns method and compositions for treating cystic fibrosis. The method comprises inducing CFTR expression in epithelial cells in a lung of a mammal by contacting the epithelial cells in the lung of the mammal with a composition, where the composition is a pharmaceutical composition comprising in vitro transcribed mRNA.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.